MedTrace Logo

CGM in Icodextrin PD

NCT06838819 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-02-21

No results posted yet for this study

Summary

Assessment of performance (precision and accuracy) of Simplera™ CGM as compared with a gold standard reference laboratory method (YSI glucose) in diabetes patients on peritoneal dialysis with icodextrin

Conditions

  • Diabetes Mellitus (Diagnosis)
  • End Stage Renal Disease (ESRD)
  • Dialysis
  • Continuous Glucose Monitoring

Interventions

DEVICE

Continuous glucose monitoring system

Medtronic Simplera™

Sponsors & Collaborators

  • Medtronic Diabetes

    collaborator INDUSTRY

  • Elaine Chow

    lead OTHER

Principal Investigators

  • Elaine Chow Clinical Associate Professor, PhD, MBChB · Department of Medicine and Therapeutics, The Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2026-08-20
Completion
2026-09-20

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06838819 on ClinicalTrials.gov